Correlation of serum IL-2 and IFN-γ levels with clinical prognosis of nasopharyngeal carcinoma patients and analysis of risk factors.

IF 4.6 3区化学 Q2 CHEMISTRY, MULTIDISCIPLINARY RSC Advances Pub Date : 2024-01-25 DOI:10.5937/jomb0-44057

Siquan Guo, Feng Qin, Jiang Wang, Yongqing Ding, Jianqiang You, Changjiang Chao

{"title":"Correlation of serum IL-2 and IFN-γ levels with clinical prognosis of nasopharyngeal carcinoma patients and analysis of risk factors.","authors":"Siquan Guo, Feng Qin, Jiang Wang, Yongqing Ding, Jianqiang You, Changjiang Chao","doi":"10.5937/jomb0-44057","DOIUrl":null,"url":null,"abstract":"Background: This study aims to investigate the correlation between serum levels of interleukin-2 (IL-2) and interferong (IFN-g) and the clinical prognosis of patients with nasopharyngeal carcinoma (NPC). Additionally, the study aims to analyse the risk factors associated with this correlation.Methods: The clinical data of 195 NPC patients admitted to our hospital from October 2020 to October 2022 were selected for a retrospective study. Based on the Glasgow score, patients were divided into two groups: the good prognosis group (group g), consisting of patients who scored 0 points, and the poor prognosis group (group p), consisting of patients who scored 1-2 points. The levels of serum IL-2 and IFN-g were compared between the two groups, and the clinical values of serum IL-2 and IFN-g in the prognosis of patients were analysed. The clinical parameters of the patients were collected, and the risk factors affecting the prognosis of NPC were analysed by univariate and multivariate logistic regression.","PeriodicalId":102,"journal":{"name":"RSC Advances","volume":"12 1","pages":"50-56"},"PeriodicalIF":4.6000,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10943460/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"RSC Advances","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5937/jomb0-44057","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: This study aims to investigate the correlation between serum levels of interleukin-2 (IL-2) and interferong (IFN-g) and the clinical prognosis of patients with nasopharyngeal carcinoma (NPC). Additionally, the study aims to analyse the risk factors associated with this correlation.

Methods: The clinical data of 195 NPC patients admitted to our hospital from October 2020 to October 2022 were selected for a retrospective study. Based on the Glasgow score, patients were divided into two groups: the good prognosis group (group g), consisting of patients who scored 0 points, and the poor prognosis group (group p), consisting of patients who scored 1-2 points. The levels of serum IL-2 and IFN-g were compared between the two groups, and the clinical values of serum IL-2 and IFN-g in the prognosis of patients were analysed. The clinical parameters of the patients were collected, and the risk factors affecting the prognosis of NPC were analysed by univariate and multivariate logistic regression.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

鼻咽癌患者血清IL-2和IFN-γ水平与临床预后的相关性及风险因素分析

研究背景本研究旨在探讨鼻咽癌（NPC）患者血清中白细胞介素-2（IL-2）和干扰素（IFN-g）水平与临床预后之间的相关性。此外，该研究还旨在分析与这种相关性有关的风险因素：方法：选取我院 2020 年 10 月至 2022 年 10 月收治的 195 例鼻咽癌患者的临床数据进行回顾性研究。根据格拉斯哥评分，将患者分为两组：预后良好组（g组），由0分患者组成；预后不良组（p组），由1-2分患者组成。比较两组患者的血清 IL-2 和 IFN-g 水平，并分析血清 IL-2 和 IFN-g 对患者预后的临床价值。收集患者的临床参数，并通过单变量和多变量逻辑回归分析影响鼻咽癌预后的危险因素。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

RSC Advances chemical sciences-

CiteScore

7.50

自引率

2.60%

发文量

3116

审稿时长

1.6 months

期刊介绍： An international, peer-reviewed journal covering all of the chemical sciences, including multidisciplinary and emerging areas. RSC Advances is a gold open access journal allowing researchers free access to research articles, and offering an affordable open access publishing option for authors around the world.